IBRX · trading date Oct 12, 2026 · previous close $10.51 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$113.29M
Net income
-$351.40M
Total assets
$501.90M
Total liabilities
$1.00B
Stockholders' equity
-$500.47M
Cash & equivalents
$88.33M
Operating income
-$256.03M
Operating cash flow
-$304.94M
Capital expenditures
$3.85M
Fiscal year 2025, via 10-K filed 2026-02-23.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-226.0%
Net margin
-310.2%
Free cash flow
-$308.78M
Free cash flow margin
-272.6%
Liabilities / assets
199.5%
Equity / assets
-99.7%
CapEx / revenue
3.4%
Operating cash flow / net income
0.87×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
San Diego, CA 92121
3530 JOHN HOPKINS COURT
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:16 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.